Posted On: 01/06/2016 6:44:04 AM
Post# of 94339
News Highlights: Top Equities Stories Of The Day
Source: Dow Jones News
Apple Scales Back Orders for iPhones
Apple is scaling back orders for its iPhones, sending ripples throughout the multibillion-dollar industry that supplies and builds the company's phones.
Samsung Says Smartwatch Will Work With Apple's iOS
Samsung Electronics said it would make its latest smartwatch compatible with Apple's operating system, underscoring the complex relationship between the smartphone makers.
Credit Suisse's U.S. Stock-Trading Chief to Leave
Credit Suisse Group's head of U.S. equities trading, Daniel Mathisson, plans to leave the bank in February and start a new business outside of banking.
Goldman Sachs Shuffles Executives, Adds Another From Morgan Stanley
Goldman Sachs recently moved several senior executives into new roles, and added another from rival, Morgan Stanley.
China's Dalian Wanda Moves Into Health Care
Dalian Wanda is investing $2.3 billion in hospital developments in China, a first foray into the health-care sector for the property and entertainment conglomerate as the government urges the expansion of private health care.
Valeant to Tap New Leader While CEO Is Hospitalized
Valeant Pharmaceuticals is planning to appoint a new chief executive while its CEO, Michael Pearson, remains under hospital care, said people familiar with the matter.
Pioneer Natural Resources to Book $1 Billion in Write-Downs
Pioneer Natural Resources Co. said it would write down the value of its oil-and-gas properties by around a $1 billion, while the oil-and-gas explorer forecast production growth and higher capital spending for 2016.
Sirius XM Added More Users Than It Forecast for 2015
Sirius XM Holdings Inc. added more subscribers than expected in 2015 but said it sees that growth slowing in 2016.
Gilead Ends a Phase 2 Study for Antibody
Gilead Sciences is ending a Phase 2 study of simtuzumab in patients with idiopathic pulmonary fibrosis, as the study hasn't shown evidence of a treatment benefit.
Yum Chairman Plans to Retire in May
Yum Brands said Executive Chairman David C. Novak plans to retire in May, following the fast-food company's annual meeting.
(END) Dow Jones Newswires
January 06, 2016 03:06 ET (08:06 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Source: Dow Jones News
Apple Scales Back Orders for iPhones
Apple is scaling back orders for its iPhones, sending ripples throughout the multibillion-dollar industry that supplies and builds the company's phones.
Samsung Says Smartwatch Will Work With Apple's iOS
Samsung Electronics said it would make its latest smartwatch compatible with Apple's operating system, underscoring the complex relationship between the smartphone makers.
Credit Suisse's U.S. Stock-Trading Chief to Leave
Credit Suisse Group's head of U.S. equities trading, Daniel Mathisson, plans to leave the bank in February and start a new business outside of banking.
Goldman Sachs Shuffles Executives, Adds Another From Morgan Stanley
Goldman Sachs recently moved several senior executives into new roles, and added another from rival, Morgan Stanley.
China's Dalian Wanda Moves Into Health Care
Dalian Wanda is investing $2.3 billion in hospital developments in China, a first foray into the health-care sector for the property and entertainment conglomerate as the government urges the expansion of private health care.
Valeant to Tap New Leader While CEO Is Hospitalized
Valeant Pharmaceuticals is planning to appoint a new chief executive while its CEO, Michael Pearson, remains under hospital care, said people familiar with the matter.
Pioneer Natural Resources to Book $1 Billion in Write-Downs
Pioneer Natural Resources Co. said it would write down the value of its oil-and-gas properties by around a $1 billion, while the oil-and-gas explorer forecast production growth and higher capital spending for 2016.
Sirius XM Added More Users Than It Forecast for 2015
Sirius XM Holdings Inc. added more subscribers than expected in 2015 but said it sees that growth slowing in 2016.
Gilead Ends a Phase 2 Study for Antibody
Gilead Sciences is ending a Phase 2 study of simtuzumab in patients with idiopathic pulmonary fibrosis, as the study hasn't shown evidence of a treatment benefit.
Yum Chairman Plans to Retire in May
Yum Brands said Executive Chairman David C. Novak plans to retire in May, following the fast-food company's annual meeting.
(END) Dow Jones Newswires
January 06, 2016 03:06 ET (08:06 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
(0)
(0)
